Verrica Pharmaceuticals Inc. (VRCA) stock
VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.14−0.06 (-1.88%)
Close on Nov 17, 2026Market cap $53.94MP/E –Yield –
Verrica Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Verrica Pharmaceuticals's price to book ratio was 15.6× on Nov 11, 2026, against 239.4× a year earlier. Over the last 5 years it ranged from 2.1× to 239.4×, with a median of 5.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 15.6× | −169.8 |
| 2024 | Jul 31, 2024 | 185.4× | +178.1 |
| 2023 | Dec 29, 2023 | 7.3× | +4.8 |
| 2022 | Dec 30, 2022 | 2.5× | −3.6 |
| 2021 | Dec 31, 2021 | 6.2× | −1.4 |
| 2020 | Dec 31, 2020 | 7.6× | +1.9 |
| 2019 | Dec 31, 2019 | 5.7× | +3.5 |
| 2018 | Dec 31, 2018 | 2.2× | – |
See a number that looks wrong?